NDLI: A qualitative assessment of the challenges of WHO prequalification for anti-malarial drugs in China

Content Provider	Springer Nature : BioMed Central
Author	Huang, Yangmu Pan, Ke Peng, Danlu Stergachis, Andy
Abstract	Background While China is a major manufacturer of artemisinin and its derivatives, it lags as a global leader in terms of the total export value of anti-malarial drugs as finished pharmaceutical products ready for marketing and use by patients. This may be due to the limited number of World Health Organization (WHO) prequalified anti-malarial drugs from China. Understanding the reasons for the slow progress of WHO prequalification (PQ) in China can help improve the current situation and may lead to greater efforts in malaria eradication by Chinese manufacturers. Methods In-depth interviews were conducted in China between November 2014 and December 2016. A total of 26 key informants from central government agencies, pharmaceutical companies, universities, and research institutes were interviewed, all of which had current or previous experience overseeing or implementing anti-malarial research and development in China. Results Chinese anti-malarial drugs that lack WHO PQ are mainly exported for use in the African private market. High upfront costs with unpredictable benefits, as well as limited information and limited technical support on WHO PQ, were reported as the main barriers to obtain WHO PQ for anti-malarial drugs by respondents from Chinese pharmaceutical companies. Potential incentives identified by respondents included tax relief, human resource training and consultation, as well as other incentives related to drug approval, such as China’s Fast Track Channel. Conclusions Government support, as well as innovative incentives and collaboration mechanisms are needed for further adoption of WHO PQ for anti-malarial drugs in China.
Related Links	https://malariajournal.biomedcentral.com/counter/pdf/10.1186/s12936-018-2303-8.pdf
Ending Page	7
Page Count	7
Starting Page	1
File Format	HTM / HTML
ISSN	14752875
DOI	10.1186/s12936-018-2303-8
Journal	Malaria Journal
Issue Number	1
Volume Number	17
Language	English
Publisher	BioMed Central
Publisher Date	2018-04-03
Access Restriction	Open
Subject Keyword	Parasitology Tropical Medicine Infectious Diseases Entomology Microbiology Public Health Malaria WHO prequalification Anti-malarial Artemisinins
Content Type	Text
Resource Type	Article
Subject	Infectious Diseases Parasitology
Journal Impact Factor	2.4/2023
5-Year Journal Impact Factor	2.6/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Synergistic anti-malarial action of cryptolepine and artemisinins

Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectives

Artemisinin resistance – modelling the potential human and economic costs

Erratum to: Synergistic anti-malarial action of cryptolepine and artemisinins

The effect of malaria and anti-malarial drugs on skeletal and cardiac muscles

The role of anti-malarial drugs in eliminating malaria

Substandard anti-malarial drugs in Burkina Faso

Spectrophotometric detection of susceptibility to anti-malarial drugs

The use of non-prescribed anti-malarial drugs for the treatment of malaria in the Bolgatanga municipality, northern Ghana

A qualitative assessment of the challenges of WHO prequalification for anti-malarial drugs in China

Similar Documents

Synergistic anti-malarial action of cryptolepine and artemisinins

Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectives

Artemisinin resistance – modelling the potential human and economic costs

Erratum to: Synergistic anti-malarial action of cryptolepine and artemisinins

The effect of malaria and anti-malarial drugs on skeletal and cardiac muscles

The role of anti-malarial drugs in eliminating malaria

Substandard anti-malarial drugs in Burkina Faso

Spectrophotometric detection of susceptibility to anti-malarial drugs

The use of non-prescribed anti-malarial drugs for the treatment of malaria in the Bolgatanga municipality, northern Ghana

A qualitative assessment of the challenges of WHO prequalification for anti-malarial drugs in China